Cincera Therapeutics Overview

  • Founded
  • 2018
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1M
Latest Deal Amount
  • Investors
  • 3

Cincera Therapeutics General Information


Developer of inflammatory and fibrotic illness drug designed to cure metabolic diseases. The company's drug treats difficult-to-treat inflammatory and fibrotic conditions associated with obesity and also has applicability in many other disease areas including cancer, and liver problems, enabling doctors to cure patients effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia

Cincera Therapeutics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cincera Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 03-Sep-2020 $1M 00.000 Completed Generating Revenue
1. Early Stage VC 19-Feb-2018 00.000 00.000 00.000 Completed Generating Revenue
To view Cincera Therapeutics’s complete valuation and funding history, request access »

Cincera Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference 0,000,000 00.00 00.00 00 00.00 00.000
To view Cincera Therapeutics’s complete cap table history, request access »

Cincera Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Bernard Flynn Co-Founder, Chief Executive Officer & Research Director
Stuart Pitson Co-Founder & Chief Scientific Officer
Roberto Solari Ph.D Advisor
To view Cincera Therapeutics’s complete executive team members history, request access »

Cincera Therapeutics Board Members (4)

Name Representing Role Since
Ben Atcliffe Ph.D Cincera Therapeutics Board Observer 000 0000
Katherine Nielsen Cincera Therapeutics Board Member 000 0000
Melissa McBurnie Ph.D Brandon Capital Board Member 000 0000
Michael Bettess Ph.D Brandon Capital Chairman 000 0000
To view Cincera Therapeutics’s complete board members history, request access »

Cincera Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cincera Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Australian Government's Department of Health Government 000 0000 000000 0
AustralianSuper Limited Partner Minority 000 0000 000000 0
Brandon Capital Venture Capital Minority 000 0000 000000 0
To view Cincera Therapeutics’s complete investors history, request access »